BDNF–VEGF interplay key to rapid antidepressant actions
A study reveals a complex interplay of two different growth factors in the rapid and long-lasting antidepressant effects of ketamine...
List view / Grid view
A study reveals a complex interplay of two different growth factors in the rapid and long-lasting antidepressant effects of ketamine...
A simple blood test reliably detects signs of brain damage in people on the path to developing Alzheimer's disease...
Genetic variants which prevent a neurotransmitter receptor from working properly have been implicated in the development of schizophrenia...
SB Drug Discovery shows the validation of fluorescence and automated electrophysiology assays designed to assess agonists, antagonists and allosteric modulators of these receptors, culminating in a high-throughput electrophysiology assay suited to assessing multiple GABAA receptor subtypes on a single assay plate.
Caffeine plus another compound in coffee beans' waxy coating may protect against brain degeneration...
Mitochondrial dysfunction has been widely implicated in the neuronal degeneration in Parkinson’s disease (PD). Mitochondria-targeted protective compounds that prevent or minimise a wide range of mitochondrial defects constitute potential therapeutic strategies in the prevention and treatment of neuronal degeneration in PD.
Scientists have made an important step towards understanding the mechanisms that cause the neurodegenerative disorder Huntington's disease...
Researchers have identified a receptor in the microglial cells that increases their anti-inflammatory potential in order to reduce the damage in MS...
Researchers identify Parkinson's disease as a possible autoimmune disease...
New research on how cannabis use alters eating behaviour could lead to treatments for appetite loss in chronic illness...